Name

Leading Technology

Legal name

Leading Technology Group

Website

https://leadingtechnology.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Investment Holding - Medical Research and Life Sciences

NAICS

Management of Companies and Enterprises (551), Research and Development in the Physical, Engineering, and Life Sciences (54171), Software Publishers (51321), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest) (FSAAADAH)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

Keywords

• Medical research investment
• Life sciences investment
• Private equity holdings
• Business acquisitions
• Portfolio management

Headquarters

HQ city

Kew

HQ country

Australia

HQ region

Oceania

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Investment Returns: LTG generates returns through acquiring and holding medical, scientific, and software businesses as a long-term investment. Revenue is derived from the operational performance of portfolio companies including clinical trial services, laboratory services, medical software distribution, and biotechnology instrumentation distribution.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Leading Technology Group is a family-owned investment company that acquires and holds businesses long-term in the medical research, life sciences, and software industries. The group operates as a permanent home for portfolio companies rather than a buy-to-sell private equity firm, completing acquisitions debt-free within months and allowing founders to remain in ongoing roles. Its active portfolio spans clinical trial services, bioanalytical laboratories, clinical trial recruitment and software, scientific instrumentation distribution, cardiovascular information systems, biotechnology research, and a cloud-based scientific knowledge platform.

Product overview

Leading Technology Group is a family-owned investment company that operates as a platform of portfolio companies rather than a single unified product. The portfolio spans clinical trial services (Veritus Research, Emeritus Research, Clinibase), bioanalytical laboratory services (Crux Biolabs), scientific instrumentation distribution (Millennium Science), healthcare information management (Cardiobase, Cardiobase), and biotechnology research (Systematic Medicine). The Group also operates ResearchAnalysis.com as a cloud-based venture providing scientific knowledge management tools. Each portfolio company operates as a distinct brand serving specific niches within medical research and life sciences.

Differentiator

Problem solved

Functional benefit

Products and services

• Veritus Research A Phase 1 clinical trial centre offering world-leading recruitment for complex diseases with a state-of-the-art Melbourne facility, rapid start-up, and high quality standards. Targeted at pharmaceutical companies and CROs needing first-in-human and early-phase trial execution.
• Emeritus Research A dedicated clinical medicine research centre in Melbourne providing services for Phase I/Ib, Phase II, Phase III and Phase IV clinical trials, including healthcare and pharmacoeconomic trials. Serves pharmaceutical companies, CROs, and research sponsors across all phases of drug development.
• Crux Biolabs A leading Australian bioanalytical laboratory providing services for contract research organizations (CROs), clinical trials, and pre-clinical trials. Provides quantitative bioanalytical analysis to support drug development programs.
• Clinibase Australia's leading clinical trial participant recruitment company, offering patient recruitment across all diseases and regions along with Clinical Trial Management Software (CTMS) and eSource services. Targeted at CROs, pharmaceutical sponsors, and research sites needing trial enrollment and management tooling.
• Millennium Science The leading distributor of high-technology instrumentation and reagents for the Australasian biotechnology research market. Supplies laboratories and research institutions with advanced scientific equipment and consumables.
• Cardiobase A cardiovascular information management system deployed across 27 hospitals in Australia, the UK, and New Zealand, providing administration, medical records, and analytics for cardiac departments. Used by hospital cardiology departments for clinical data capture and reporting.
• Systematic Medicine A research company focused on identifying novel targets and therapeutic strategies to modulate the root causes of the ageing process. Conducts biotechnology and ageing-related therapeutic research.
• ResearchAnalysis.com A cloud-based platform that enables scientists to capture scientific claims from literature in a structured form and explore these claims using powerful search to identify conflicts and gaps in the body of knowledge. Targeted at scientists and research teams seeking literature analysis and knowledge management tooling.

Quantifiable outcome

• 18 successful acquisitions completed over 20 years
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• ResearchAnalysis.comcoreStrategic or Co-development PartnerVenture launched by LTG to accelerate scientific discovery through cloud-based platforms providing practical knowledge and reasoning tools for scientists. The platform enables capture of scientific claims from literature in structured form and exploration using powerful search to find conflicts and gaps in body of knowledge.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Clinipace Worldwide: Mid-sized full-service CRO with technology-enabled clinical trial management. Comparable to LTG's CRO and Clinibase software stack, though smaller in scale and focused on specific therapeutic areas.

Direct peers

• Nucleus Network (CMAX Clinical Research): Australian Phase 1 clinical trial operator with early-phase capabilities. Closely comparable to Veritus Research's Phase 1 specialization, serving the same sponsor base for complex early-phase studies in Australia.
• BioAgilytix: Specialized bioanalytical laboratory services provider for large molecule, small molecule, and biomarker assays in clinical and pre-clinical trials. Closely mirrors Crux Biolabs' positioning as a focused bioanalytical lab serving CRO and pharma clients.
• Planet Innovation: Australian healthtech product development and commercialization company that builds, invests in, and scales medical and life sciences ventures. Comparable as a homegrown Australian platform aggregating healthtech and life sciences assets with a multi-portfolio operating model similar to LTG.
• Novotech: Australian-headquartered full-service CRO serving pharma and biotech sponsors across Asia-Pacific and globally. Directly comparable to Veritus Research and Emeritus Research, which together comprise LTG's clinical trial services arm and compete for similar sponsor relationships.

Broad incumbents

• ICON plc: Global CRO and clinical research services provider across all trial phases. Overlaps with Veritus, Emeritus, and Crux Biolabs across the same sponsor customers and competes for the same multi-phase and bioanalytical work.
• Eurofins Scientific: Global bioanalytical and laboratory services group serving pharmaceutical and CRO customers. Direct overlap with Crux Biolabs' bioanalytical lab offering for clinical and pre-clinical trials, with substantially greater geographic and assay breadth.
• Charles River Laboratories: Global provider of preclinical and clinical laboratory services, including bioanalytical offerings. Comparable to Crux Biolabs as a bioanalytical lab serving CROs and pharma sponsors, with much broader global capacity.
• Veeva Systems: Global life sciences cloud software provider including CTMS (Veeva Vault CTMS) and clinical operations platforms. Competes with Clinibase's CTMS and eSource offering, representing the scaled software incumbent in the same category.
• IQVIA: Global full-service CRO and life sciences technology provider. Competes with LTG's CRO subsidiaries for large pharmaceutical sponsor contracts and represents the scaled, incumbent version of the clinical research services market LTG's portfolio operates in.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks4 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leading Technology